Sample Request

COVID-19 Outbreak-Global RNA-interference (RNAi) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

SELECT LICENSE:

Published on 12/15/2020| Code: MAR41115D| Category: Utilities| Total Pages: 115

RNA interference is a biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. Historically, RNAi was known by other names, including co-suppression, post-transcriptional gene silencing, and quelling.

The RNA-interference (RNAi) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the RNA-interference (RNAi) industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The RNA-interference (RNAi) market can be split based on product types, major applications, and important countries as follows:

Key players in the global RNA-interference (RNAi) market covered in Chapter 12:

Tekmira Pharmaceuticals Corporation
Phio Pharmaceuticals Corp.
Quark Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
Dicerna Pharmaceuticals
Silence Therapeutics PLC
Qiagen NV
Arrowhead
Merck & Co. Inc. (Sigma Aldrich)
ISIS Pharmaceuticals
Alnylam Pharmaceuticals
Thermo Fisher Scientific Inc.
Benitec Biopharma Ltd
Arcturus Therapeutics
RXI Pharmaceuticals

In Chapter 4 and 14.1, on the basis of types, the RNA-interference (RNAi) market from 2015 to 2025 is primarily split into:

Chemical synthesis
In vitro transcription
In vivo expression

In Chapter 5 and 14.2, on the basis of applications, the RNA-interference (RNAi) market from 2015 to 2025 covers:

Drug Discovery and Development
Therapeutics

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 RNA-interference (RNAi) Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of RNA-interference (RNAi)

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the RNA-interference (RNAi) industry

1.4 Methodology of The Study

1.5 Research Data Source

2 Executive Summary

2.1 Market Overview

2.1.1 Global RNA-interference (RNAi) Market Size, 2015 – 2020

2.1.2 Global RNA-interference (RNAi) Market Size by Type, 2015 – 2020

2.1.3 Global RNA-interference (RNAi) Market Size by Application, 2015 – 2020

2.1.4 Global RNA-interference (RNAi) Market Size by Region, 2015 - 2025

2.2 Business Environment Analysis

2.2.1 Global COVID-19 Status and Economic Overview

2.2.2 Influence of COVID-19 Outbreak on RNA-interference (RNAi) Industry Development

3 Industry Chain Analysis

3.1 Upstream Raw Material Suppliers of RNA-interference (RNAi) Analysis

3.2 Major Players of RNA-interference (RNAi)

3.3 RNA-interference (RNAi) Manufacturing Cost Structure Analysis

3.3.1 Production Process Analysis

3.3.2 Manufacturing Cost Structure of RNA-interference (RNAi)

3.3.3 Labor Cost of RNA-interference (RNAi)

3.4 Market Distributors of RNA-interference (RNAi)

3.5 Major Downstream Buyers of RNA-interference (RNAi) Analysis

3.6 The Impact of Covid-19 From the Perspective of Industry Chain

3.7 Regional Import and Export Controls Will Exist for a Long Time

3.8 Continued downward PMI Spreads Globally

4 Global RNA-interference (RNAi) Market, by Type

4.1 Global RNA-interference (RNAi) Value and Market Share by Type (2015-2020)

4.2 Global RNA-interference (RNAi) Production and Market Share by Type (2015-2020)

4.3 Global RNA-interference (RNAi) Value and Growth Rate by Type (2015-2020)

4.3.1 Global RNA-interference (RNAi) Value and Growth Rate of Chemical synthesis
4.3.2 Global RNA-interference (RNAi) Value and Growth Rate of In vitro transcription
4.3.3 Global RNA-interference (RNAi) Value and Growth Rate of In vivo expression
4.4 Global RNA-interference (RNAi) Price Analysis by Type (2015-2020)

5 RNA-interference (RNAi) Market, by Application

5.1 Downstream Market Overview

5.2 Global RNA-interference (RNAi) Consumption and Market Share by Application (2015-2020)

5.3 Global RNA-interference (RNAi) Consumption and Growth Rate by Application (2015-2020)

5.3.1 Global RNA-interference (RNAi) Consumption and Growth Rate of Drug Discovery and Development (2015-2020)
5.3.2 Global RNA-interference (RNAi) Consumption and Growth Rate of Therapeutics (2015-2020)

6 Global RNA-interference (RNAi) Market Analysis by Regions

6.1 Global RNA-interference (RNAi) Sales, Revenue and Market Share by Regions

6.1.1 Global RNA-interference (RNAi) Sales by Regions (2015-2020)

6.1.2 Global RNA-interference (RNAi) Revenue by Regions (2015-2020)

6.2 North America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

6.3 Europe RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

6.4 Asia-Pacific RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

6.5 Middle East and Africa RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

6.6 South America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

7 North America RNA-interference (RNAi) Market Analysis by Countries

7.1 The Influence of COVID-19 on North America Market

7.2 North America RNA-interference (RNAi) Sales, Revenue and Market Share by Countries

7.2.1 North America RNA-interference (RNAi) Sales by Countries (2015-2020)

7.2.2 North America RNA-interference (RNAi) Revenue by Countries (2015-2020)

7.3 United States RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

7.4 Canada RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

7.5 Mexico RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8 Europe RNA-interference (RNAi) Market Analysis by Countries

8.1 The Influence of COVID-19 on Europe Market

8.2 Europe RNA-interference (RNAi) Sales, Revenue and Market Share by Countries

8.2.1 Europe RNA-interference (RNAi) Sales by Countries (2015-2020)

8.2.2 Europe RNA-interference (RNAi) Revenue by Countries (2015-2020)

8.3 Germany RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8.4 UK RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8.5 France RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8.6 Italy RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8.7 Spain RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8.8 Russia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9 Asia Pacific RNA-interference (RNAi) Market Analysis by Countries

9.1 The Influence of COVID-19 on Asia Pacific Market

9.2 Asia Pacific RNA-interference (RNAi) Sales, Revenue and Market Share by Countries

9.2.1 Asia Pacific RNA-interference (RNAi) Sales by Countries (2015-2020)

9.2.2 Asia Pacific RNA-interference (RNAi) Revenue by Countries (2015-2020)

9.3 China RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9.4 Japan RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9.5 South Korea RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9.6 India RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9.7 Southeast Asia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9.8 Australia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

10 Middle East and Africa RNA-interference (RNAi) Market Analysis by Countries

10.1 The Influence of COVID-19 on Middle East and Africa Market

10.2 Middle East and Africa RNA-interference (RNAi) Sales, Revenue and Market Share by Countries

10.2.1 Middle East and Africa RNA-interference (RNAi) Sales by Countries (2015-2020)

10.2.2 Middle East and Africa RNA-interference (RNAi) Revenue by Countries (2015-2020)

10.3 Saudi Arabia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

10.4 UAE RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

10.5 Egypt RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

10.6 Nigeria RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

10.7 South Africa RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

11 South America RNA-interference (RNAi) Market Analysis by Countries

11.1 The Influence of COVID-19 on Middle East and Africa Market

11.2 South America RNA-interference (RNAi) Sales, Revenue and Market Share by Countries

11.2.1 South America RNA-interference (RNAi) Sales by Countries (2015-2020)

11.2.2 South America RNA-interference (RNAi) Revenue by Countries (2015-2020)

11.3 Brazil RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

11.4 Argentina RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

11.5 Columbia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

11.6 Chile RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

12 Competitive Landscape

12.1 Tekmira Pharmaceuticals Corporation
12.1.1 Tekmira Pharmaceuticals Corporation Basic Information
12.1.2 RNA-interference (RNAi) Product Introduction
12.1.3 Tekmira Pharmaceuticals Corporation Production, Value, Price, Gross Margin 2015-2020
12.2 Phio Pharmaceuticals Corp.
12.2.1 Phio Pharmaceuticals Corp. Basic Information
12.2.2 RNA-interference (RNAi) Product Introduction
12.2.3 Phio Pharmaceuticals Corp. Production, Value, Price, Gross Margin 2015-2020
12.3 Quark Pharmaceuticals Inc.
12.3.1 Quark Pharmaceuticals Inc. Basic Information
12.3.2 RNA-interference (RNAi) Product Introduction
12.3.3 Quark Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
12.4 Ionis Pharmaceuticals Inc.
12.4.1 Ionis Pharmaceuticals Inc. Basic Information
12.4.2 RNA-interference (RNAi) Product Introduction
12.4.3 Ionis Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
12.5 Dicerna Pharmaceuticals
12.5.1 Dicerna Pharmaceuticals Basic Information
12.5.2 RNA-interference (RNAi) Product Introduction
12.5.3 Dicerna Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.6 Silence Therapeutics PLC
12.6.1 Silence Therapeutics PLC Basic Information
12.6.2 RNA-interference (RNAi) Product Introduction
12.6.3 Silence Therapeutics PLC Production, Value, Price, Gross Margin 2015-2020
12.7 Qiagen NV
12.7.1 Qiagen NV Basic Information
12.7.2 RNA-interference (RNAi) Product Introduction
12.7.3 Qiagen NV Production, Value, Price, Gross Margin 2015-2020
12.8 Arrowhead
12.8.1 Arrowhead Basic Information
12.8.2 RNA-interference (RNAi) Product Introduction
12.8.3 Arrowhead Production, Value, Price, Gross Margin 2015-2020
12.9 Merck & Co. Inc. (Sigma Aldrich)
12.9.1 Merck & Co. Inc. (Sigma Aldrich) Basic Information
12.9.2 RNA-interference (RNAi) Product Introduction
12.9.3 Merck & Co. Inc. (Sigma Aldrich) Production, Value, Price, Gross Margin 2015-2020
12.10 ISIS Pharmaceuticals
12.10.1 ISIS Pharmaceuticals Basic Information
12.10.2 RNA-interference (RNAi) Product Introduction
12.10.3 ISIS Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.11 Alnylam Pharmaceuticals
12.11.1 Alnylam Pharmaceuticals Basic Information
12.11.2 RNA-interference (RNAi) Product Introduction
12.11.3 Alnylam Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.12 Thermo Fisher Scientific Inc.
12.12.1 Thermo Fisher Scientific Inc. Basic Information
12.12.2 RNA-interference (RNAi) Product Introduction
12.12.3 Thermo Fisher Scientific Inc. Production, Value, Price, Gross Margin 2015-2020
12.13 Benitec Biopharma Ltd
12.13.1 Benitec Biopharma Ltd Basic Information
12.13.2 RNA-interference (RNAi) Product Introduction
12.13.3 Benitec Biopharma Ltd Production, Value, Price, Gross Margin 2015-2020
12.14 Arcturus Therapeutics
12.14.1 Arcturus Therapeutics Basic Information
12.14.2 RNA-interference (RNAi) Product Introduction
12.14.3 Arcturus Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.15 RXI Pharmaceuticals
12.15.1 RXI Pharmaceuticals Basic Information
12.15.2 RNA-interference (RNAi) Product Introduction
12.15.3 RXI Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

13.1 Market Driver Analysis

13.1.2 Market Restraints Analysis

13.1.3 Market Trends Analysis

13.2 Merger, Acquisition and New Investment

13.3 News of Product Release

14 Global RNA-interference (RNAi) Market Forecast

14.1 Global RNA-interference (RNAi) Market Value & Volume Forecast, by Type (2020-2025)

14.1.1 Chemical synthesis Market Value and Volume Forecast (2020-2025)
14.1.2 In vitro transcription Market Value and Volume Forecast (2020-2025)
14.1.3 In vivo expression Market Value and Volume Forecast (2020-2025)
14.2 Global RNA-interference (RNAi) Market Value & Volume Forecast, by Application (2020-2025)

14.2.1 Drug Discovery and Development Market Value and Volume Forecast (2020-2025)
14.2.2 Therapeutics Market Value and Volume Forecast (2020-2025)
14.3 RNA-interference (RNAi) Market Analysis and Forecast by Region

14.3.1 North America Market Value and Consumption Forecast (2020-2025)

14.3.2 Europe Market Value and Consumption Forecast (2020-2025)

14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)

14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)

14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

15.1 Industry Barriers and New Entrants SWOT Analysis

15.1.1 Porter’s Five Forces Analysis

15.1.2 New Entrants SWOT Analysis

15.2 Analysis and Suggestions on New Project Investment

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp
AutoX
A.JAFFE
Aaga Marketing
AGRIC SA
Alcimed
AMSEC
Aquanova
AYTB Industrial
Bain & Company
Brooks Life Sciences
Cirona Labs
CMV Informatics
CONNEMARAORGANIC SEAWEED COMPANY
Desmet Ballestra Group
Dine4Fit, a.s.
Dream Incubator Vietnam Joint Stock Company
DSM
Eastman Chemical
Edwards Vacuum
Emerson
Getinge
Hello Flexibles
Industrie Beteiligungs Gesellschaft IBG
Inscripta, Inc.
JLL Technologies
Kari-Out
Marafie Engineering Co
Monitor Deloitte
Mossif3
mpumalanga stainless initiative
Nextteq, LLC
Pattern
Phizzle
Phronesis Partners Pte. Ltd.
PSP Specialties
Reno Refractories, Inc.
Roche Diagnostics International Ltd.
Rockfield Medical Device
RSG Media
Sealed Air
Sutton Capital Partners, Inc
Tenshi LifeCare Pvt Ltd (Velbiom Probiotics PVt Ltd)
The Crocodile Integrated Marketing Ltd
Tomorrow.io
UL
Vibrant Marketing
Wild Republic
ams OSRAM
Atelerix Life Sciences Inc
Beckman Coulter Life Sciences
BIOTECH VISION CARE PVT. LTD
Chiripal
Circle NVI
Freudenberg Filtration Technologies SE & Co. KG
FTA HSRP Solutions Pvt Ltd
Goetz Partners
Good clean love
Hasso Plattner d-school at UCT
InnoFaith Beauty Sciences
INSALA
Kukuza Consulting
MilliporeSigma
Panasonic Industry Europe
Quintus Technologies
Renesas
Roche Diagnostics International Ltd.
Timee, Inc.
YCP Solidiance
Graffer
Magnus
Pantex Ennerflo
The Japan Association of Bonded Magnetic Materials
SIS
Elian
RS Connect
3 Hunters Talent Solutions LATAM
Atelerix Life Sciences Inc
David Clark
DSGLOBAL CO.,LTD.
Hitotsubashi University
kovis-group
Saunacore
Suez Consulting
WestRock
Medeon Biodesign
Power Transmission Consulting, PTC AB
Sint Maartenskliniek
ITW Specialty Films
American Fuji Seal, Inc.
Tag-consultants.com
HAZEMAG Systems GmbH
Dabur International
lippert componentrs
Aelea Commodities Private Limited
ERRIA A/S
Chiripal Group
Capstone Partners
VETTEX SRL
Ægir Advisory Services
John Deere
ADTEC Plasma Technology
Cairneagle
Mckinsey
Panasonic Consumer Electronics Company
ACT
Mele & Co
SAZKA a.s.
THIN
Assurance Services International
Intro-act Inc
School of Health Sciences/Democritus University of Thrace
W.L.Gore
Nippon Steel Co.
AFB International
986 Labs
Bamboi
Zaptin Communications LLC

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005